Sionna Therapeutics, Inc. Common Stock SION Ratios & Valuation
| FY'25 | ||
|---|---|---|
| Returns | ||
| Return on assets | -29.4%— | |
| Liquidity | ||
| Current ratio | 20.6×+6.1× | |
| Quick ratio | 20.6×+6.1× | |
| Cash ratio | 5.1×+1.4× | |
| Leverage | ||
| Debt-to-equity | 0×— | |
| Debt-to-assets | 0×0.0× | |
| Per Share | ||
| Book value per share | $7.68+118% | |
| Valuation | ||
| Market capitalization | $1.84B— | |
| Enterprise value | $1.79B— | |
| Price / book | 6×— | |
| Free cash flow yield | -3.6%— | |
| Earnings yield | -4.1%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Sionna Therapeutics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Sionna Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.